Audio

Mark Freedman, MD

Publish date: July 24, 2013

The Promise of Mesenchymal Stem Cells for Patients With MS

 

Recommended Reading

Anti-JCV Antibody Index May Further Define PML Risk
MDedge Neurology
Fingolimod Slows MS Brain Atrophy Within Six Months
MDedge Neurology
Recommendations outline how to improve dimethyl fumarate tolerability
MDedge Neurology
Simvastatin May Reduce Brain Atrophy in Patients With Secondary Progressive MS
MDedge Neurology
Transverse myelitis does not share risk factors with MS
MDedge Neurology
Evidence of delayed cancer detection in MS patients
MDedge Neurology
Urinary symptoms often unaddressed in MS
MDedge Neurology
Medical marijuana: Tips from an expert
MDedge Neurology
Is MS therapy getting to be too much for general neurologists?
MDedge Neurology
Evidence-based medical marijuana for MS symptoms
MDedge Neurology

Related Articles